Clozapine treatment parameters

Other clinical indications in schizophrenia patients include sensitivity to extrapyramidal side effects and patients with tardive dyskinesia.

Other contributing mechanisms may include cytokine release and high levels of catecholamines. In a report of cases of life-threatening gastrointestinal hypomotility suspected to be caused by clozapineconsiderable mortality was seen largely due to bowel resection along with a mortality rate of In a comparative effectiveness study of patients who initiated clozapine, intestinal obstruction emerged as a clinically significant adverse effect, seen in a greater proportion of clozapine patients compared with patients on a standard antipsychotic 0.

In a review of patients treated with clozapine, the cumulative seizure risk was estimated to be 10 percent after 3.

Latest views

Schizophr Bull ; During admission, contact the relevant clozapine monitoring service with relevant FBC results as required and confirm the FBC is acceptable before dispensing more clozapine.

Routine neutrophil monitoring is performed at the following intervals:. Some hospitals have a liaison psychiatry team that can advise and monitor mental health patients and their psychiatric conditions during acute admissions.

While both were associated with a reduced rate of drooling, a larger decrease was seen in the group taking glycopyrrolate. Search the site Search. See "Evaluation and management of treatment-resistant schizophrenia", section on 'Clozapine trial' and "Second-generation antipsychotic medications: Although there is no routine monitoring for myocarditis or cardiomyopathy during treatment, patients showing signs of heart failure should have their therapy stopped until the condition is investigated.

The elimination half-life of clozapine averages approximately 14 hours under steady state conditions, but there is substantial variability across individuals [ 5 ].

The progressive increases in obesity, diabetes, elevated triglycerides, and hypertension in their population resulted in substantially increased cardiovascular risk.

Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? The true risk is likely closer to the 1 in rate, as often only a minority of adverse medication-related events are diagnosed and reported.

Sharon Williams 21 FEB Revisions to United States regulations in permitted clinicians to override ANC-based treatment recommendations to continue or restart clozapine in patients where the benefits of clozapine clearly exceed the risk of agranulocytosis.

See "Management of neuropsychiatric symptoms of dementia", section on 'Excess mortality'. BNF 74 September is your essential reference book for prescribing, dispensing, and administering medicines.

Choose an option to locate/access this article:

See 'Benign ethnic neutropenia' above. Subsequent clozapine use in the United States and other countries has been subject to required, regular monitoring and registry reporting of absolute neutrophil counts ANC [ 1 ], a process that has succeeded in avoiding deaths due to this adverse effect.

The drug is subject to strict monitoring requirements because it is associated with serious side effects, such as neutropenia, agranulocytosis, seizures, myocarditis and cardiomyopathy.

Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight: